Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Zebrafish larvae are used to study and find treatments for ear cell damage because they are easier to observe and test than mammals.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

A new hand-held light therapy device was found to be safe and effective for treating mild-to-moderate acne.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

A new hair transplant method showed promising results and a study found how deep a CO₂ laser can penetrate skin.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

Natural products in cosmetics are beneficial for skin and hair care with low toxicity.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

Washing can prevent cancer from lubricating oils, extreme body temperatures need more study, Sulfomid is not recognized, no reliable diphtheria carrier treatment except surgery, eyelid injuries should heal before repair, heterophile antibody test is specific for mononucleosis, chlorine inhalations for colds are outdated, and wheat germ is safe.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.